Definitive Healthcare Corp. (NASDAQ:DH) Short Interest Down 9.2% in November

Definitive Healthcare Corp. (NASDAQ:DH) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 2,460,000 shares, a drop of 9.2% from the November 15th total of 2,710,000 shares. Approximately 5.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 425,400 shares, the days-to-cover ratio is presently 5.8 days.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. BTIG Research started coverage on Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective for the company. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Definitive Healthcare has a consensus rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Stock Performance

NASDAQ:DH remained flat at $4.46 during mid-day trading on Tuesday. The company’s stock had a trading volume of 306,224 shares, compared to its average volume of 717,595. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $10.62. The stock has a market capitalization of $515.23 million, a price-to-earnings ratio of -1.42, a P/E/G ratio of 3.29 and a beta of 1.40. The company has a fifty day moving average price of $4.41 and a two-hundred day moving average price of $4.71.

Insider Activity

In related news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 14.84% of the stock is currently owned by corporate insiders.

Institutional Trading of Definitive Healthcare

Hedge funds have recently modified their holdings of the company. Hennion & Walsh Asset Management Inc. bought a new stake in shares of Definitive Healthcare in the 2nd quarter valued at $127,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Definitive Healthcare by 31.4% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after acquiring an additional 5,083 shares in the last quarter. Principal Financial Group Inc. raised its position in shares of Definitive Healthcare by 10.8% during the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock worth $218,000 after purchasing an additional 3,874 shares during the period. Rhumbline Advisers raised its position in shares of Definitive Healthcare by 19.7% during the second quarter. Rhumbline Advisers now owns 83,751 shares of the company’s stock worth $457,000 after purchasing an additional 13,764 shares during the period. Finally, Victory Capital Management Inc. lifted its holdings in shares of Definitive Healthcare by 1.9% during the 2nd quarter. Victory Capital Management Inc. now owns 509,009 shares of the company’s stock valued at $2,779,000 after purchasing an additional 9,316 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.